Long Term Care Journal
Monday, December 23, 2019
FDA approves new treatment for adults with migraine - FDA Press Releases
FDA approves Ubrelvy (ubrogepant) tablets for the acute treatment of migraine with or without aura in adults.
from FDA Press Releases RSS Feed https://ift.tt/2sW0Vd7
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment